A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Conditions:  Central Nervous System Nongerminomatous Germ Cell Tumor;  Embryonal Carcinoma;  Immature Teratoma;  Malignant Teratoma;  Mixed Germ Cell Tumor;  Pineal Region Germ Cell Tumor;  Pineal Region Immature Teratoma;  Pineal Region Yolk Sac Tumor Interventions:  Drug: Carboplatin;  Drug: Etoposide;  Biological: Filgrastim;  Drug: Ifosfamide;  Drug: Mesna;  Biological: Pegfilgrastim;  Procedure: Peripheral Blood Stem Cell Transplantation;  Other: Questionnaire Administration;  Radiation: Radiation Therapy;  Drug: Thiotepa Sponsor:  Children's OncologyÂ...
Source: ClinicalTrials.gov - December 24, 2020 Category: Research Source Type: clinical trials
A Phase 1 Study to Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy Subjects
Condition:  Healthy Interventions:  Drug: QL0605;  Drug: US Neulasta Sponsor:  Qilu Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2020 Category: Research Source Type: clinical trials
Severe Bullous Drug Eruption and Filgrastim
Conditions:  Rare Diseases;  Toxic Epidermal Necrolyses Interventions:  Drug: Filgrastim;  Drug: Placebo Sponsor:  Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2020 Category: Research Source Type: clinical trials
A Phase 1 Study to Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy Subjects
Condition:  Healthy Interventions:  Drug: QL0605;  Drug: US Neulasta Sponsor:  Qilu Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2020 Category: Research Source Type: clinical trials
Severe Bullous Drug Eruption and Filgrastim
Conditions:  Rare Diseases;  Toxic Epidermal Necrolyses Interventions:  Drug: Filgrastim;  Drug: Placebo Sponsor:  Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2020 Category: Research Source Type: clinical trials
A Phase 1 Study to Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy Subjects
Condition:  Healthy Interventions:  Drug: QL0605;  Drug: US Neulasta Sponsor:  Qilu Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2020 Category: Research Source Type: clinical trials
Severe Bullous Drug Eruption and Filgrastim
Conditions:  Rare Diseases;  Toxic Epidermal Necrolyses Interventions:  Drug: Filgrastim;  Drug: Placebo Sponsor:  Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2020 Category: Research Source Type: clinical trials
